Back to results
US 10,766,922 B2Granted
Substituted steroids for the treatment of cancer
AssigneeAquavan Technology Co., Ltd
InventorsKuo-Tang Tseng, Hsin Ju Wang, Wen-Hung Chen
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeAquavan Technology Co., Ltd
InventorsKuo-Tang Tseng, Hsin Ju Wang, Wen-Hung Chen
Estimating the term…
A compound and pharmaceutically acceptable salts thereof for treating cancer, having a structure represented by the following formula (I) or formula (II): in which X and Y each individually represent: R1, R2, R3, R4, and R5 individually represents hydrogen atom, acyl having 20 or less carbon atoms, alkyl having 20 or less carbon atoms, alkanoyl having 20 or less carbon atoms, aroyl having 20 or less carbon atoms, aryl having 20 or less carbon atoms, aralkyl having 20 or less carbon atoms, sulfonyl having 20 or less carbon atoms, phosphonyl having 20 or less carbon atoms, or haloacyl having 20 or less carbon atoms.
A method for inhibiting a cancer cell proliferation in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, a pharmaceutically acceptable excipient, and/or a pharmaceutically acceptable adjuvant and a compound represented by formula (vi):
Dependencies are inferred from the claim text.